期刊
ONCOLOGY LETTERS
卷 16, 期 2, 页码 2319-2325出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2018.8924
关键词
microRNA-23a/27a/24-2 cluster; gastric cancer; suppressor of cytokine-induced signaling 6
类别
资金
- Yen Tjing Ling Medical Foundation [CI-100-16, CI-103-14]
- Center of Excellence for Cancer Research at Taipei Veterans General Hospital [DOH101-TD-C-111-007, DOH102-TD-C-111-007, MOHW103-TD-B-111-02]
- Ministry of Education
- Aim for the Top University Plan [101AC-T406, 103AC-T607, 104AC-T506]
- Ministry of Science and Technology, Taiwan [MOST105-2319-B-010-001]
Previous studies have indicated that certain microRNAs (miRNAs/miRs) function as either tumor suppressors or oncogenes in human cancer. The present study identified the miR-23a/27a/24-2 cluster, containing miR-23, miR-27a and miR-24, as an oncogene in gastric cancer. The expression of the miR-23a/27a/24-2 cluster was upregulated in clinical gastric cancer tissues. Transfection with inhibitors of miR-23a, miR-27a, or miR-24, either independently or together, repressed in vitro colony formation and in vivo tumor formation. The miR23a/27a/24-2 cluster inhibitors repressed the growth of gastric cancer cells in a synergistic manner. In addition, treatment with lower doses of the miRNA inhibitor mixture induced the formation of apoptotic bodies. According to computational predictions using TargetScan, suppressor of cytokine-induced signaling 6 (SOCS6) was identified as one of the downstream target genes of the miR-23a/27a/24-2 cluster. The expression of SOCS6 was significantly lower in tumor tissues than in matched normal tissues (P<0.01) and was associated with poor survival (P<0.00001). Taken together, these results strongly suggested that the miR-23a/27a/24-2 cluster may mediate the progression of gastric cancer through the suppression of SOCS6 expression. The present study also provides a novel molecular target for the development of an anti-gastric cancer agent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据